Infinity Pharmaceuticals, Inc. (INFIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Infinity Pharmaceuticals Market Cap
Infinity Pharmaceuticals has a market cap or net worth of $91.00 as of August 22, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
91.00
Enterprise Value
n/a
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 13, 2006, Infinity Pharmaceuticals's market cap has decreased from 48.47M to 91.00, a decrease of -100.00%. That is a compound annual growth rate of -50.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 91.00 | - |
| Dec 31, 2024 | 91.00 | -99.96% |
| Dec 29, 2023 | 226.90K | -99.54% |
| Dec 30, 2022 | 49.59M | -75.24% |
| Dec 31, 2021 | 200.28M | 47.14% |
| Dec 31, 2020 | 136.12M | 148.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |